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Abstract
Background
Despite having similar palliative needs to patients with lung cancer, advanced chronic
obstructive pulmonary disease (COPD) patients are less likely to receive palliative care. To
evaluate the effect of introducing specialized palliative care with severe to very severe
COPD patients, a randomized controlled trial (RCT) was conducted in Switzerland.
Aim
To explore COPD patients’ recollection of the trial, their needs and the usefulness of the pal-
liative care interventions.
Design and setting
Qualitative study with advanced COPD patients who participated in a specialized palliative
care intervention, conducted in a general hospital.
Method
Eighteen patients with severe to very severe COPD were interviewed about their experi-
ences. Interviews were transcribed and thematic content analysis was performed.
Results
Patients had poor recollection of the trial and difficulties understanding the palliative care
intervention. No major differences were observed between patients who received the spe-
cialized intervention and those who did not. Content analysis emphasized that although they
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experienced disabling symptoms, participants tended to attribute their limitations to prob-
lems other than COPD and some declared that they were not sick. Patients reported restric-
tions due to oxygen therapy, and the burden of becoming dependent on it. This dependence
resulted in intense anxiety, leading participants to focus on the present only. A strong feeling
of perceived helplessness emerged from the patients’ interviews.
Conclusions
Our findings suggest that poor recollection and understanding of the palliative care interven-
tion act as barriers to the conduct of clinical trials with severe and very severe COPD
patients. Their cognitive difficulties, perception of COPD, functional limitations, overwhelm-
ing anxiety, focus on the present and perceived helplessness also seem to hinder the imple-
mentation of such care.
1. Introduction
Chronic obstructive pulmonary disease (COPD) is a progressive lung disorder that causes
important mortality and morbidity worldwide [1]. Severe COPD is associated with disabling
physical symptoms, emotional distress, social isolation and poor quality of life [2, 3]. The ill-
ness trajectory of COPD has been described as one of long-term limitations with recurrent
exacerbations that can result in death [4]. Within 2 years after admission for an acute exacer-
bation, mortality rates are between 36–50% [5].
The unpredictable illness trajectory of COPD makes it difficult to determine prognosis and
can be a barrier to the provision of palliative care for these patients [6]. Despite having similar
palliative needs to patients with lung cancer, studies have shown that COPD patients are less
likely to receive palliative care than patients with lung cancer [2, 7]. Many COPD patients have
limited access to palliative care services [2, 8–10]. Furthermore, patients with moderate to
severe COPD often report infrequent and poor-quality communication about end-of-life care
with their physicians [11, 12].
A randomized controlled trial (RCT) was conducted in Switzerland to evaluate the effect of
introducing specialized palliative care for patients with severe and very severe COPD [13]. The
primary objective of this study was to assess the impact of early specialized palliative care on
hospital, intensive care unit and emergency admissions of these patients. Preliminary results
show no significant differences between the intervention and control group in terms of exacer-
bation, hospital and intensive care unit admissions, or on scores for anxiety and depression.
The results of the trial will be presented elsewhere.
Little is known about the views of advanced COPD patients on palliative care. To better under-
stand the experiences of these patients with a specialized palliative care consultation, we undertook
a qualitative study as a supplement to the above-mentioned RCT. More specifically, we investigated
their recollection of participating in the trial and their particular needs at this stage of the disease.
The results of this study could provide insights as to how patients suffering from this life-threatening
lung disease remember and benefit from palliative care interventions and, conversely, on the possi-
ble barriers to the conduct of clinical trials and the introduction of such care with these patients.
2. Material and methods
2.1 Design/Sampling
The randomized controlled trial [13] was a 3-year single center study with a 2 arms parallel
groups design. Inclusion criteria were patients with COPD defined according to the Global
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Initiative for Chronic Obstructive Lung Disease (GOLD) criteria with a stage III or IV disease
and/or long-term treatment with domiciliary oxygen and/or home mechanical ventilation
and/or one or more hospital admissions in the previous year for an acute exacerbation. Exclu-
sion criteria were patients with cognitive impairment (<23 on the Mini Mental State Examina-
tion (MMSE)) and/or with active cancer and/or in their last days of life.
The 49 patients included were randomly allocated either to the intervention group that
benefited from an early specialized palliative care intervention in addition to standard care, or
to the control group that benefited from standard care. The early palliative care intervention
consisted of the visit of experienced nurses specialized in palliative care once a month during
one year, and focused on symptom management, nutrition, understanding of illness and cop-
ing with the disease, anticipation and decision-making, support of relatives, socio-spiritual
needs, coordination between different health providers and proposing alternative approaches
such as relaxation, reflexology and massages.
At the end of the trial, the research team informed surviving participants that a psychologist
(CV) would contact them for an interview about their participation in the study and their experi-
ence with COPD. Among the 49 patients included in the RCT, 17 patients died since the begin-
ning of the trial. The follow-up of 7 patients was interrupted during the trial, leaving only 25
patients to contact for an interview. Among those, 4 patients could not or did not want to be inter-
viewed notably because of their poor health condition, 2 individuals could not be joined by tele-
phone and one person was living abroad. Eighteen semi-structured interviews were finally
conducted with the surviving patients between October and December 2016 (Fig 1).
The study was approved by the Cantonal Research Ethics Committee in Geneva CCER
(n˚PB_2016–02208 (13–102) and the trial has been registered at clinicaltrials.gov under
NCT02223780. Informed written consent was obtained from all patients before the interviews.
In terms of procedures, the consolidated criteria for reporting qualitative research (COREQ)
were followed [14].
2.2 Data collection
A psychologist (CV) carried out the interviews with patients alone at their home. In order to
obtain in-depth qualitative information, two topic guides (one for the intervention group, one
Fig 1. Flow chart of sampling.
https://doi.org/10.1371/journal.pone.0204701.g001
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for the control group) were developed from reference to the literature and brainstorming with
the multidisciplinary research team (one pulmonologist JPJ, two palliative care doctors CW
and SP, two psychologists CC and CV) (S1 Text). The interview guides focused on patient’s
participation to the study (expectations), their opinions on the specialized palliative care
received/usual care received (overall appreciation, information received, symptom manage-
ment, psychological support, spiritual support, advanced directives), support from family and
friends (support received, needs, involvement in the care provided), the needs and usefulness
of a specialized palliative care and their unmet needs. After a first question inviting the patients
to share their experience of their participation in the trial, open-ended questions were used to
generate further narratives in relation to the topics of the interview guide. All interviews were
tape recorded, anonymized and transcribed (S2 Text). Field notes were taken after each
interview.
2.3 Data analysis
Using thematic content analysis methods [15], two research psychologists (CC and CV) simul-
taneously and independently read and analyzed the interviews. The analysis led to the identifi-
cation of recurring categories and themes. Iterative analysis was performed throughout data
collection until no new categories and themes emerged from transcript analysis [16, 17]. CC
and CV met frequently to discuss their findings and to reach consensus on the qualitative anal-
ysis grid. The grid was then submitted to the research team (JPJ, CW, SP) for verification [18],
with the transcripts of two interviews, and modified in light of their review. Interview coding
was performed in Microsoft Excel spread sheets, using the final grid. Finally, the multidisci-
plinary research team (JPJ, CW, SP, CC, CV) discussed the findings according to their areas of
expertise and previous research findings until the emergence of a consensus.
3. Results
Among the 18 interviews conducted (10 men, 8 women), 11 patients had been randomized to
the palliative care group of the RCT (7 men, 4 women) and 7 patients to the usual care group
(3 men, 4 women). Patients were aged between 56 and 82 years old (Table 1). There were no
significant differences between the subgroup of patients interviewed and the total of patients
included in the RCT for socio-demographic, anthropometric and subjective variables. Inter-
views lasted 52 minutes on average.
Table 1. Characteristics of the 18 patients interviewed.
Sex (male/female) 10/8
Age (years; mean (SD; range)) 72 (7; 56–82)
Living with family carer (number of patients) 4
Domiciliary oxygen (number of patients) 10
FEV1 (%; mean (SD))a 35.4 (18.6)
Hospitalisations during the year (number of patients) 11
Hospital anxiety and depression scale, anxiety subscore (mean (SD))b 8.6 (4.3)
Hospital anxiety and depression scale, depression subscore (mean (SD))c 5.7 (3.3)
Data collected at RCT inclusion, except for participants’ age registered at interview.
a FEV1 = forced expiratory volume in one second.
b Scores between 8 and 10 indicate a suspected anxiety disorder.
c Scores up to 7 indicate an absence of depression disorder.
https://doi.org/10.1371/journal.pone.0204701.t001
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3.1 Overview of findings
The first finding of this study is that no major differences could be observed between the
group of patients who received a specialized palliative care intervention and those who
benefited from standard care. Because of this lack of differences, we decided to carry out a sin-
gle thematic content analysis for the whole of the 18 interviews that focuses on patients’ experi-
ences of the trial and of living with COPD. The key findings of this analysis can be grouped
into the following topics: (1) “nothing was done for me”, (2) “I’m not sick”, (3) functional limi-
tations, (4) overwhelming anxiety, (5) focus on the present and (6) perceived helplessness.
3.2 “Nothing was done for me”
A majority of participants related a lack of understanding of the purpose of the study and ques-
tioned its usefulness. The patients in the intervention group mainly remembered completing
study questionnaires but did not seem to remember and/or acknowledge the palliative care
consultation as such.
“Well, we didn’t talk much, we did this questionnaire, and then they [the research nurses]
would leave, so. No, there wasn’t any discussion like I have with you [interviewer] today (. . .).
There wasn’t any discussion besides the questionnaire.” (Participant 11, palliative care, male,
56 years old)
Moreover, two patients couldn’t remember at all the palliative care intervention.
“But I can’t remember, I can’t remember, you can’t remove it from me. I don’t want to talk
nonsense to say, because I don’t know, so, honestly. I can’t even tell you how those ladies [the
nurses] were. Probably nice, but. . .” (Participant 10, palliative care, male, 73 years old)
Whether they belonged to the intervention or control group, most patients described that
nothing was done for them as the nurses didn’t change their medication, improve their lung
function nor helped with their other functional limitations.
“But, but what did she come to do to me? She didn’t do anything to me! I continued as I have
always done! So she was there to say hello to me, and that’s it! I don’t know! Because I can’t
recall having changed treatments, or whatever, I can’t remember! I have the same treatment
since the beginning, so I don’t know why, I don’t know, no.” (Participant 10, palliative care,
male, 73 years old)
For 3 participants, this lack of effect was in particular explained by the fact that a nurse and
not a doctor performed the visits.
“Well, listen, if it’s done by a doctor, OK. But if it’s done by a nurse, she can at the most report
to the doctor what she has seen, but, but she can’t do better! It’s not her who’s going to change
your treatment.” (Participant 6, usual care, female, 74 years old)
Only 3 patients in the intervention group reported that the monthly visits were useful. The
information provided, the skills of the nurses and the support received for the management of
their anxiety figured among the elements that were appreciated.
“She [nurse] especially brought me practical elements that nobody else could give me, in fact.
Doctors don’t treat us like that. So she did the transition between the simply human side,
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banal questions and the doctor who never answers those questions: ‘how should I eat’ or ‘what
I could do to breathe better’.” (Participant 14, palliative care, female, 70 years old)
The components of the palliative care interventions such as symptom management, nutri-
tion, disease information, or alternative approaches were rarely mentioned by the patients
who benefited from this care. Indeed, patients rather reported that what they appreciated in
the nurses’ home visits was having companionship, talking about other subjects than their ill-
ness and the moral support provided.
“It was pleasant to have the visit of this lady [nurse], to indulge in small talk. But I mean, it
didn’t bring me anything, by telling me, by optimizing, by telling me ‘I’m going to live for
another 10 years’.” (Participant 9, palliative care, male, 70 years old)
3.3 “I’m not sick”
Although they suffered from advanced COPD with disabling symptoms, participants tended
to talk more about other health problems they suffered from than about their COPD. More-
over, some attributed their functional limitations to aging rather than their illness and 5
patients even declared that they were not sick.
“But I’m OK, I cope with it, you tell me: ‘you have a radiant glow’. I say: ‘yes, but I’m not sick,
that’s it’ (laughs).” (Participant 2, usual care, female, 74 years old)
“Yeah, I never believed in COPD. (. . .). I didn’t feel sick actually.” (Participant 18, usual care,
male, 78 years old)
Participants thus appeared to privilege avoidant coping strategies such as denial or distrac-
tion over active coping strategies such as anticipation or information seeking.
“And all of this I managed to evacuate, not thinking about the illness anymore but rather
about silly things, jokes, puns. And it’s a way for me to evacuate basically. And that’s what
saves me a bit. (. . .). If we think about it, we keep talking about it, it becomes burdensome.
Yes. Too burdensome.” (Participant 7, palliative care, male, 71 years old)
3.4 Functional limitations
Most patients expressed suffering from restrictions in daily activities. In particular, all but 2
participants reported difficulties in moving from one place to another because of dyspnea, oxy-
gen therapy and/or aging. With the worsening of COPD, patients then mentioned the burden
of becoming dependent on others and on oxygen to help them function.
“And I felt dependent all the same. I felt tied to here in the house, the wire is 15 meters long. I
felt as if I was kept on a leash! And I couldn’t do anything without it.” (Participant 3, usual
care, female, 78 years old)
“We already have the constraint at the end of the line, so you can keep the rest of constraints.”
(Participant 6, usual care, female, 74 years old)
Furthermore, the difficulties encountered by patients in organizing oxygen therapy were
seen as barriers to engaging in activities such as shopping for food, taking public transports or
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participating in social encounters. Some participants also shared that oxygen therapy exposed
them to stigmatization, which could lead to social isolation.
“With my illness, I can walk, I can breathe, it’s ok. I could continue like that, if I remain stable,
why not. But the oxygen is destroying me. . . It’s the oxygen. I only feel sick now. Before I was
sick, but we couldn’t see it. It means that I knew it, but people didn’t see it. (. . .) Maybe I’m less
breathless when I walk, it’s true. But in my head, no, morally no it’s not helping me.” (Partici-
pant 15, palliative care, female, 70 years old)
This sense of stigma, increased limitations of daily activities, feeling of dependence and
unpredictable aggravation of COPD were identified as major sources of suffering.
3.5 Overwhelming anxiety
Throughout the patients’ interviews, a strong feeling of living in a constant state of anxiety
emerged. Anxiety was related to the fear of running out of oxygen (with oxygen therapy), hav-
ing a respiratory distress, the aggravation of their COPD and death.
“So it stresses me out and it’s frightening to always be dependent on oxygen, on tubes (. . .).
And it’s a very, very frightening disease, I have to say. (. . .) if there’s a power cut, I’m out of
oxygen. (. . .) so you’re always at the mercy of a technical problem. And a person who is, who
can move around, she opens the window, she can breathe, she’s thirsty, she will be able to go
and get water. We are very handicapped by this problem.” (Participant 6, usual care, female,
74 years old)
Moreover, they felt physically vulnerable to climate changes, microbes or technical prob-
lems with their oxygen supplies and at the mercy of their unpredictable disease. This anxiety
was strongly associated to the dependence on others and on oxygen therapy generated by the
worsening of COPD and the increase of functional limitations.
3.6 Focus on the present
It appeared through the interviews that the patients tended to focus on the present and avoid
talking about the future.
“So, I knew more or less what to expect. Even if we refuse to believe or think about what hap-
pens next. No, no, we want to live the moment but we don’t want to know what happens next.
And when you’re in the moment after, it’s difficult to accept.” (Participant 6, usual care,
female, 74 years old)
Participants shared indeed living one day at a time and adapting their daily activities
according to how they felt and to the weather. Throughout the interviews, narratives on the
history of their COPD were poor and discussions about end-of-life issues were often avoided.
As a matter of fact, some patients clearly eluded advance directives regarding end-of-life care.
“And I still have the brochure [on advance directives] here, I know exactly what it is, what. But
when I’ll be, when I’ll be up to it, when I’ll feel better, when maybe I’ll be set differently in my
mind, yes I’ll do it (laughs).” (Participant 4, palliative care, female, 68 years old)
When asked about their specific needs, they mostly reported practical needs to help with
their daily functioning and didn’t wish for any spiritual support. Moreover, most participants
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expressed wanting to be cured and to be able to breathe. Some wished to be supported and to
have their anxiety reduced.
3.7 Perceived helplessness
A strong feeling of perceived helplessness emerged from the patients’ interviews. COPD was
described as an incurable affection that caused a progressive and inevitable deterioration of
their lungs.
“And then that’s it, we go down a step, we try to go back up. But you go down two steps, you go
back up only one!” (Participant 6, usual care, female, 74 years old)
“Anyway, it’s not going away. It’s not curable, if it was something that we could cure like a can-
cer or like that, then I would get informed. But there I don’t inform myself, it’s like that!” (Par-
ticipant 3, usual care, female, 78 years old)
In the same way, most participants mentioned that they didn’t expect anything from their
participation in the trial and that they participated for science advances rather than for
themselves.
“Nothing. I didn’t expect anything. I knew it wouldn’t improve my health at all.” (Participant
9, palliative care, male, 70 years old)
However, most patients expressed the wish to be healed and half of them were hoping for
medical advances for COPD.
“Yes if you find another, a good medication, let me know! I will take it (laughs). Something so I
don’t need to take this [oxygen therapy] anymore. They will find something one day! They will
find something that you put under your skin that will make oxygen and that we won’t have to
fill and everything. For sure, they will find something.” (Participant 10, palliative care, male,
73 years old)
“I would like a medication that makes me go back to how I was last year, so I can get better.”
(Participant 6, usual care, female, 74 years old)
4. Discussion
4.1 Barriers to conducting clinical trials with advanced COPD patients
The findings of this qualitative study provide insights as to possible barriers to conducting clin-
ical trials and implementing palliative care interventions for people suffering from advanced
COPD. The particular way in which COPD affects individuals at various levels may explain
the surprising lack of recall, understanding and benefit of the palliative care intervention. As
we already knew and as shown through the interviews, advanced COPD not only impairs their
body, but also disturbs them at the affective, cognitive, psychological and social levels. For
instance, several studies have demonstrated that cognitive dysfunctions are frequent in COPD
patients, notably due to persistent hypoxemia [19–21]. Although cognitive function was not or
slightly impaired at the beginning of the study, as indicated by the MMSE scores of these
patients, we thus may assume that cognitive difficulties could have affected patients’ ability to
remember the intervention at the time of the interview.
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The fact that some patients with advanced COPD did not see themselves as sick also seems
to be a major obstacle to the identification of a need for palliative care. This non-recognition
of COPD as a disease was also found in other studies. Patients with severe COPD have previ-
ously described COPD as a “way of life” rather than an illness [22] or as a “vague feeling of
being ill” [23]. Habraken et al [24] suggested that COPD patients did not ask for help because
they did not see themselves as ill. Patients did not regard their limitations as abnormal but as
part of ageing, which concurs with our findings and those of others [25]. The specific illness
trajectory of COPD brings patients to adapt to their limitations and feel sick only during exac-
erbations [22, 24]. Our findings thus suggest a lack of comprehension of COPD and its prog-
nosis in some patients with advanced COPD. Several studies have revealed this inadequate
provision of information and the need for improved communication about end-of-life care for
these patients [2, 11, 12, 23, 26–30].
Furthermore, the anxiety expressed through the interviews seems to lead patients to live
one day at a time and focus on the present as thinking about the future appears to be too fright-
ening. It feels as though COPD imposes a restriction of their mental horizon by narrowing
their activities, mobility, social contacts, pulmonary and cognitive capacities and life expec-
tancy. These increasing limitations in COPD have been well documented [23, 24, 31, 32] and
seem to trap patients into a state of dependency and anxiety. If they cannot have “new lungs”
or a miracle cure, patients then wish for practical solutions to help them function on a daily
basis and therefore regain a sense of control over their lives. These primary needs could con-
tribute to explain their reluctance to discuss advance directives. Our findings are in line with
those of Marx et al who describe the attempts of severe COPD patients to maintain life as usual
and to deny the threat to life for as long as possible [23].
The fact that most participants did not recognize palliative care as something useful could
also be linked to their strong feeling of perceived helplessness. Other studies have described
this feeling of “being at the mercy of the disease” [23], that they cannot be helped [24] and this
form of “passive acceptance” [22]. As they feel that nothing can be done for them, patients
tend to avoid actively seeking for information and help for their illness and thus seem to not
know about available support besides their actual treatment. This lack of knowledge can be
illustrated by the idea shared by several participants that “real” care can only be provided by a
doctor who can change their treatment and not by a nurse. As reported by Spathis and Booth
[33], there appears to be some misconceptions about palliative care and COPD that act as bar-
riers to the provision of end-of-life care for these patients.
4.2 Strengths and limitations of the study
The 18 patients interviewed were a sample of a population selected for the RCT and thus may
differ from an unselected population of patients with advanced COPD. In particular, partici-
pants in the trial had a higher level of education and a rather high proportion of home care by
various care providers. The numerous healthcare visits could thus have hindered the identifi-
cation of the palliative care received as part of the study. Moreover, the delay between the end
of the RCT and the interview (4 to 17 months) could have contributed to the difficulty for par-
ticipants to recall the intervention. The fact that the study questionnaires (every 3 months) and
the palliative care intervention (every month) occurred in the same lapse of time could have
participated to the sense of confusion among patients in the “palliative care” group. Finally, we
cannot exclude that the cognitive status of certain patients may have deteriorated since initial
screening for participation in the trial (MMSE). As this was designed as a qualitative study, we
did not seek to generalize our results but to obtain a better understanding of patients’ experi-
ences with a specialized palliative care consultation. In this context, the most notable limitation
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is the common challenge of transferability of the findings. As in all qualitative studies, our
study sample was small and the exploration of experiences calling upon recall memory in this
specific population indicates that the transferability may thus be limited to people and settings
with characteristics similar to those investigated in this study.
Regardless of these limitations, our findings on patients’ experiences of living with
advanced COPD are in line with other qualitative studies [22–24]. Besides contributing to the
comprehension of these specific experiences, the use of qualitative research methods helped to
better understand the lack of effects of the palliative intervention of the RCT. The usefulness of
qualitative methods alongside RCTs to better understand complex healthcare interventions
has repeatedly been underlined [34, 35]. Discussing with the multidisciplinary research team
the results of the RCT in light of the findings of the qualitative study enriched the understand-
ing of the effect of the intervention. To our knowledge, this is the first qualitative study on
severe to very severe COPD patients who received early palliative care in the form of monthly
visits of an experienced nurse.
4.3 Implications for practice and research
Specific needs in advanced COPD should be assessed before implementing palliative care.
According to our results, it may be assumed that care should first focus on addressing anxiety
and functional limitations issues before discussing advance directives. Bove et al recently
showed that home-based psychoeducation for patients with advanced COPD helped them
self-manage anxiety and dyspnea and thus increased their sense of control [36]. Hence, educa-
tion and better information on available support could help to reduce patients’ feelings of per-
ceived helplessness. Other types of interventions, such as peer support [37, 38], mentioned as
beneficial by some participants in our study, may also provide moral support, tips on how to
deal with COPD, and reduce social isolation and sense of stigma. As for daily life limitations, a
multidisciplinary team could help patients deal with these constraints and should focus on the
difficulties encountered with oxygen therapy.
When conducting research on severe and very severe COPD, the possible difficulties
encountered by patients in recalling and understanding clinical interventions should be con-
sidered. In order to avoid recall bias, the lengths of time between each intervention, and
between the trial and interviews when using mixed methods research, should be as short as
possible.
5. Conclusions
Besides contributing to the comprehension of the experience of living with advanced COPD,
the use of qualitative research methods helped to better understand patients’ recall of the trial
and the lack of effects of the palliative care intervention. Although studies advocate the imple-
mentation of early palliative care for advanced COPD [2, 8, 39–41], different barriers still hin-
der the introduction of such care. Further research is needed to deeper comprehend patients’
needs [8], understanding and appreciation of palliative care. The use of qualitative research
before trial [34] could provide insights on the most adequate configuration of palliative care
interventions for these patients.
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